A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells (Q33756928)

29 July 2017

1 reference

title

A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells (English)

1 reference

29 July 2017

0 references

Thorley-Lawson DA

1

1 reference

PubMed ID

10530796

29 July 2017

Babcock GJ

series ordinal

2

1 reference

PubMed ID

10530796

29 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 July 2017

21

1 reference

inferred from page(s)

published in

Life Sciences

1 reference

29 July 2017

65

1 reference

29 July 2017

14

1 reference

29 July 2017

1433-1453

1 reference

Epstein-Barr virus susceptibility of normal human B lymphocyte populations

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Early events in Epstein-Barr virus infection provide a model for B cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

EBV persistence in memory B cells in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Reticular crypt epithelium and intra-epithelial lymphoid cells in the hyperplastic human palatine tonsil: an immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Human marginal-zone B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus superinduces a new human b cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus latent gene expression during the initiation of B cell immortalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Germinal center development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Maintenance of B-cell memory by long-lived cells generated from proliferating precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

B-cell memory is short-lived in the absence of antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Five human mature B cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Germinal center founder cells display propensity for apoptosis before onset of somatic mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Generation of memory B cells and plasma cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

The CD40 antigen and its ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Is EBV persistence in vivo a model for B cell homeostasis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

A novel form of Epstein-Barr virus latency in normal B cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

B-T lymphocyte interactions in the generation and survival of memory cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Endogenous TGF-beta contributes to the induction of the EBV lytic cycle in two Burkitt lymphoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein-Barr virus: adaptation to a life within the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Viral latency and transformation: the strategy of Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

THE ORIGIN OF HODGKIN AND REED/STERNBERG CELLS IN HODGKIN'S DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Role of epithelium in EBV persistence and pathogenesis of B-cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Virology: Epstein–Barr virus in epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

Epstein-Barr virus latent messages with shuffled leader exons: remnants of circumgenomic transcription?

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900214-3

7 January 2021

10.1016/S0024-3205(99)00214-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10530796